• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FUS-LATS1/2轴通过激活Hippo通路抑制肝细胞癌进展。

A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.

作者信息

Bao Le, Yuan Lei, Li Pengfei, Bu Qingyun, Guo Aijun, Zhang Hui, Cui Ning, Liu Bin

机构信息

Department of Intervention, Xuzhou Cancer Hospital, Xuzhou Hospital Affiliated to Jiangsu University, Xuzhou, China.

Department of Intervention, Xuzhou City Hospital of TCM, Xuzhou, China.

出版信息

Cell Physiol Biochem. 2018;50(2):437-451. doi: 10.1159/000494155. Epub 2018 Oct 11.

DOI:10.1159/000494155
PMID:30308519
Abstract

BACKGROUND/AIMS: The roles and related mechanisms of RNA binding protein FUS (fused in sarcoma/translocated in liposarcoma) are unclear in numerous cancers, including hepatocellular carcinoma (HCC).

METHODS

Quantitative reverse transcription PCR (qRT-PCR), western blot, cell viability, transwell migration and invasion, tumor spheres formation and in vivo tumor formation assays were used to examine the effects of FUS on HCC progression in HuH7 and MHCC97 cells. Additionally, transcriptome analysis based on RNA-sequencing data, qRT-PCR, western blots, luciferase reporter and RNA binding protein immunoprecipitation (RIP) assays were used to explore the LATS1/2 (large tumor suppressor kinases 1/2)-related mechanisms contributing to FUS functions. Finally, qRT-PCR and western blot analysis were used to detect the levels of FUS and LATS1/2 in HCC and adjacent normal tissues, and the correlation between them in HCC tissues.

RESULTS

Overexpression of FUS decreased cell viability, migration, invasion and stemness. Moreover, FUS interacted and stabilized LATS1/2 stability, and thus promoted LATS1/2 expression and activated Hippo pathway. Finally, FUS and LAST1/2 levels were positively correlated and significantly down-regulated in HCC tissues.

CONCLUSION

We demonstrate that FUS/LATS1/2 axis inhibits HCC progression via activating Hippo pathway.

摘要

背景/目的:在包括肝细胞癌(HCC)在内的多种癌症中,RNA结合蛋白FUS(肉瘤融合蛋白/脂肪肉瘤易位蛋白)的作用及其相关机制尚不清楚。

方法

采用定量逆转录PCR(qRT-PCR)、蛋白质免疫印迹法、细胞活力检测、Transwell迁移和侵袭实验、肿瘤球形成实验以及体内肿瘤形成实验,研究FUS对HuH7和MHCC97细胞中HCC进展的影响。此外,基于RNA测序数据的转录组分析、qRT-PCR、蛋白质免疫印迹法、荧光素酶报告基因实验以及RNA结合蛋白免疫沉淀(RIP)实验,用于探索与FUS功能相关的LATS1/2(大肿瘤抑制激酶1/2)相关机制。最后,通过qRT-PCR和蛋白质免疫印迹分析检测HCC及癌旁正常组织中FUS和LATS1/2的水平,以及它们在HCC组织中的相关性。

结果

FUS过表达降低细胞活力、迁移、侵袭和干性。此外,FUS相互作用并稳定LATS1/2的稳定性,从而促进LATS1/2表达并激活Hippo信号通路。最后,FUS和LAST1/2水平呈正相关,且在HCC组织中显著下调。

结论

我们证明FUS/LATS1/2轴通过激活Hippo信号通路抑制HCC进展。

相似文献

1
A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.FUS-LATS1/2轴通过激活Hippo通路抑制肝细胞癌进展。
Cell Physiol Biochem. 2018;50(2):437-451. doi: 10.1159/000494155. Epub 2018 Oct 11.
2
Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1.长链非编码 RNA HOXA11-AS 通过调控 LATS1 的表达促进肝癌细胞的增殖。
Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3402-3411.
3
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.MEIS2C 和 MEIS2D 通过 Wnt/β-catenin 和 hippo/YAP 信号通路促进肝癌的肿瘤进展。
J Exp Clin Cancer Res. 2019 Oct 17;38(1):417. doi: 10.1186/s13046-019-1417-3.
4
A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.一种新型长链非编码RNA uc.134通过抑制CUL4A介导的LATS1泛素化来抑制肝细胞癌进展。
J Hematol Oncol. 2017 Apr 19;10(1):91. doi: 10.1186/s13045-017-0449-4.
5
miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.miR-29c-3p 通过调控 DNMT3B 和 LATS1 的甲基化抑制肝癌的肿瘤进展。
Cell Death Dis. 2019 Jan 18;10(2):48. doi: 10.1038/s41419-018-1281-7.
6
Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.长链非编码RNA SchLAH通过与肉瘤融合蛋白相互作用抑制肝细胞癌转移。
Cancer Sci. 2017 Apr;108(4):653-662. doi: 10.1111/cas.13200. Epub 2017 Apr 17.
7
Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.Yes相关蛋白的敲低抑制了MHCC97H人肝癌细胞的增殖并下调了大肿瘤抑制因子1的表达。
Mol Med Rep. 2015 Jun;11(6):4101-8. doi: 10.3892/mmr.2015.3257. Epub 2015 Jan 26.
8
Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.长链非编码RNA SPRY4-IT1的过表达通过激活肝细胞癌中的EZH2促进肿瘤细胞增殖和侵袭。
Biomed Pharmacother. 2017 Jan;85:348-354. doi: 10.1016/j.biopha.2016.11.035. Epub 2016 Nov 28.
9
TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.TNFAIP8与LATS1相互作用,并通过调控肝细胞癌中的Hippo信号通路促进肿瘤侵袭性。
Oncotarget. 2017 Feb 28;8(9):15689-15703. doi: 10.18632/oncotarget.14938.
10
LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.LMO3 通过与 LATS1 直接相互作用并抑制 Hippo 信号通路促进肝细胞癌侵袭、转移和抗失巢凋亡。
J Exp Clin Cancer Res. 2018 Sep 15;37(1):228. doi: 10.1186/s13046-018-0903-3.

引用本文的文献

1
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential.探索肝细胞癌中的RNA结合蛋白:对其机制及治疗潜力的见解
J Exp Clin Cancer Res. 2025 Apr 24;44(1):130. doi: 10.1186/s13046-025-03395-7.
2
Regulatory roles of RNA binding proteins in the Hippo pathway.RNA结合蛋白在Hippo信号通路中的调控作用。
Cell Death Discov. 2025 Jan 31;11(1):36. doi: 10.1038/s41420-025-02316-z.
3
LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.
LINC00659 通过招募 FUS 和调节 SLC10A1 来阻断有氧糖酵解抑制肝癌恶性进展。
Anal Cell Pathol (Amst). 2023 May 17;2023:5852963. doi: 10.1155/2023/5852963. eCollection 2023.
4
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.肝细胞癌和肝内胆管癌的预后及治疗靶点研究进展:河马信号通路
Front Oncol. 2022 Aug 12;12:937957. doi: 10.3389/fonc.2022.937957. eCollection 2022.
5
Long noncoding RNA SOX2OT promotes pancreatic cancer cell migration and invasion through destabilizing FUS protein via ubiquitination.长链非编码RNA SOX2OT通过泛素化使FUS蛋白不稳定,从而促进胰腺癌细胞的迁移和侵袭。
Cell Death Discov. 2021 Sep 22;7(1):261. doi: 10.1038/s41420-021-00640-8.
6
Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.神经嵴细胞和转移性癌症中上皮-间充质转化过程的保守性。
Cells Tissues Organs. 2021;210(3):151-172. doi: 10.1159/000516466. Epub 2021 Jul 2.
7
lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1.长链非编码RNA DUXAP8通过上调FOXM1促进肝癌的多种恶性表型及对PARP抑制剂的耐药性。
Mol Ther Oncolytics. 2020 Oct 22;19:308-322. doi: 10.1016/j.omto.2020.10.010. eCollection 2020 Dec 16.
8
Rox8 promotes microRNA-dependent messenger RNA decay.Rox8 促进 microRNA 依赖的信使 RNA 降解。
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30520-30530. doi: 10.1073/pnas.2013449117. Epub 2020 Nov 17.
9
LINC00205 promotes malignancy in lung cancer by recruiting FUS and stabilizing CSDE1.LINC00205 通过招募 FUS 并稳定 CSDE1 促进肺癌的恶性转化。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20190701.
10
Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma.LINC00662基因敲低可抑制AK4表达并减弱口腔鳞状细胞癌的放射抗性。
Cancer Cell Int. 2020 Jun 16;20:244. doi: 10.1186/s12935-020-01286-9. eCollection 2020.